CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,841,313 | -51.5% | 212,257 | -40.2% | 0.00% | 0.0% |
| Q2 2023 | $12,042,470 | -7.4% | 354,921 | -1.8% | 0.00% | 0.0% |
| Q1 2023 | $13,007,382 | +90.4% | 361,517 | +135.8% | 0.00% | 0.0% |
| Q4 2022 | $6,832,581 | +85.6% | 153,300 | +17.0% | 0.00% | – |
| Q3 2022 | $3,682,000 | +67.2% | 130,990 | +60.3% | 0.00% | – |
| Q2 2022 | $2,202,000 | -64.3% | 81,722 | -54.8% | 0.00% | -100.0% |
| Q1 2022 | $6,161,000 | +68.8% | 180,894 | +91.5% | 0.00% | – |
| Q4 2021 | $3,649,000 | +156.4% | 94,437 | +258.3% | 0.00% | – |
| Q3 2021 | $1,423,000 | +234.8% | 26,360 | +107.7% | 0.00% | – |
| Q2 2021 | $425,000 | +27.6% | 12,692 | -21.3% | 0.00% | – |
| Q1 2021 | $333,000 | +60.9% | 16,133 | +36.4% | 0.00% | – |
| Q4 2020 | $207,000 | -6.3% | 11,832 | -20.5% | 0.00% | – |
| Q3 2020 | $221,000 | +22000.0% | 14,884 | +27983.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 53 | -45.9% | 0.00% | – |
| Q1 2020 | $0 | – | 98 | -54.4% | 0.00% | – |
| Q4 2019 | $0 | – | 215 | -16.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 258 | +20.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 215 | +182.9% | 0.00% | – |
| Q1 2019 | $0 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |